A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 5, 2008, Pages

  Mizuguchi, Yasunori ^a   Chen, Jie ^a   Seshan, Surya V ^a   Poppas, Dix P ^a   Szeto, Hazel H ^a   Felsen, Diane ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Fibrosis; Mitochondria; Peptides

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CALVASCULIN; CASPASE 3; CHEMOKINE RECEPTOR CCR1; CYTOKINE; DEXTRO ARGININE 2',6 DIMETHYLTYROSYLLYSYLPHENYLALANINAMIDE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDE; PEROXIDASE; SODIUM CHLORIDE; SS 31; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; FIBROBLAST; KIDNEY FIBROSIS; KIDNEY TUBULE; KIDNEY TUBULE DAMAGE; MACROPHAGE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; SIGNAL TRANSDUCTION; UNILATERAL URETERAL OBSTRUCTION; URETER OBSTRUCTION;

EID: 57349111179     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00395.2007     Document Type: Article

References (44)

1. Barraclough R. Calcium-binding protein S100A4 in health and disease. Biochim Biophys Acta 1448: 190-199, 1998.
2. Cho J, Won K, Soong Y, Liu S, Szeto HH, Hong MK. Potent mitochondria-targeted peptides reduce myocardial infarction in rats. Coronary Artery Dis 18: 215-220, 2007.
3. Cho S, Szeto HH, Kim Pinto JT HJ. A novel cell permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36. J Biol Chem 282: 4634-4642, 2007.
4. Covey MV, Murphy MP, Hobbs CE, Smith RA, Oorschot DE. Effect of the mitochondrial antioxidant, Mito Vitamin E, on hypoxic-ischemic striatal injury in neonatal rats: a dose-response and stereological study. Exp Neurol 199: 513-519, 2006.
5. Docherty NG, O'Sullivan OE, Healy DA, Fitzpatrick JM, Watson RW. Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am J Physiol Renal Physiol 290: F4-F13, 2006.
6. Eis V, Luckow B, Vielhauer V, Siveke JT, Linde Y, Segerer S, Perez De Lema G, Cohen CD, Kretzler M, Mack M, Horuk R, Murphy PM, Gao JL, Hudkins KL, Alpers CE, Grone HJ, Schlondorff D, Anders HJ. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction. J Am Soc Nephrol 15: 337-47, 2004.
7. El Chaar M, Chen J, Seshan SV, Jha S, Richardson I, Ledbetter S, Vaughan, ED Jr, Poppas DP, Felsen D. The effect of combination therapy with enalapril and the TGF- antagonist 1D11 in unilateral ureteral obstruction. Am J Physiol Renal Physiol 292: F1291-F1301, 2007.
8. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 305: 626-629, 2004.
9. Gulmi F, Felsen D, Vaughan ED Jr. Pathophysiology of urinary tract obstruction. In: Campbell's Urology (8th ed.,) edited by Walsh P, Retik A, Vaughan ED, Jr., and Wein A. Philadelphia, PA: Saunders, 2002.
10. Ito K, Chen J, Seshan S, Khodadadian J, Gallagher R, Chaar M, Vaughan E, Poppas D, Felsen D. Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats. Kidney Int 68: 515-528, 2005.
11. Iwano M, Plieth D, Danoff T, Xue C, Okada H, Neilson E. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350, 2002.
12. Jauslin M, Meier T, Smith R, Murphy M. Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J 17: 1972-1974, 2003.
13. Jones E, Shahed A, Shoskes D. Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction. Urology 56: 346-351, 2000.
14. Kawada N, Moriyama T, Ando A, Fukunaga M, Miyata T, Kurokawa K, Imai E, Hori M. Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. Kidney Int 56: 1004-1013, 1999.
15. Kiley S, Thornhill B, Tang S, Ingelfinger J, Chevalier R. Growth factor-mediated phosphorylation of proapoptotic BAD reduces tubule cell death in vitro and in vivo. Kidney Int 63: 33-42, 2003.
16. Kim JH, Yang JI, Jung MH, Hwa JS, Kang KR, Park DJ, Roh GS, Cho GJ, Choi WS, Chang SH. Heme oxygenase-1 protects rat kidney from ureteral obstruction via an antiapoptotic pathway. J Am Soc Nephrol 17: 1373-1381, 2006.
17. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283: F861-F875, 2002.
18. Kuemmerle N, Brandt R, Chan W, Krieg R, Chan J. Inhibition of transforming growth factor beta 1 induction by dietary vitamin E in unilateral ureteral obstruction in rats. Biochem Mol Med 61: 82-86, 1997.
19. Miyajima A, Chen J, Kirman I, Poppas DP, Darracott Vaughan ED Jr, Felsen D. Interaction of nitric oxide and transforming growth factor-beta1 induced by angiotensin II and mechanical stretch in rat renal tubular epithelial cells. J Urol 164: 1729-1734, 2000.
20. Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, Jha S, Pigato J, Lemer ML, Poppas DP, Vaughan ED, Felsen D. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58: 2301-2313, 2000.
21. Miyajima A, Chen J, Poppas DP, Vaughan ED Jr, Felsen D. Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney Int 59: 1290-1303, 2001.
22. Miyajima A, Kosaka T, Seta K, Asano T, Umezawa K, Hayakawa M. Novel nuclear factor kappa B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction. J Urol 169: 1559-1563, 2003.
23. Moriyama T, Kawada N, Nagatoya K, Takeji M, Horio M, Ando A, Imai E, Hori M. Fluvastatin suppresses oxidative stress and fibrosis in the interstitium of mouse kidneys with unilateral ureteral obstruction. Kidney Int 59: 2095-2103, 2001.
24. Murphy MP, Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol Epub October 2, 2006.
25. Pat B, Yang T, Kong C, Watters D, Johnson D, Gobe G. Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int 67: 931-943, 2005.
26. Petrie S, Kiaei M, Damiano M, Hiller A, Wille E, Manfredi G, Calingasan NY, Szeto HH, Beal MF. Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. J Neurochem 98: 1141-1149, 2006.
27. Power R, Doyle B, Higgins D, Brady H, Fitzpatrick J, Watson R. Mechanical deformation induced apoptosis in human proximal renal tubular epithelial cells is caspase dependent. J Urol 171: 457-461, 2004.
28. Radisky D, Levy D, Littlepage L, Liu H, Nelson C, Fata J, Leake D, Godden E, Albertson D, Nieto M, Werb Z, Bissell M. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436: 123-127, 2005.
29. Rhyu D, Yang Y, Ha H, Lee G, Song J, Uh S, Lee H. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 16: 667-675, 2005.
30. Ricardo S, Ding G, Eufemio M, Diamond J. Antioxidant expression in experimental hydronephrosis: role of mechanical stretch and growth factors. Am J Physiol Renal Physiol 272: F789-F798, 1997.
31. Saborio P, Krieg R, Kuemmerle N, Norkus E, Schwartz C, Chan J. Alpha-tocopherol modulates lipoprotein cytotoxicity in obstructive nephropathy. Pediatr Nephrol 14: 740-746, 2000.
32. Satoh M, Kashihara N, Yamasaki Y, Maruyama K, Okamoto K, Maeshima Y, Sugiyama H, Sugaya T, Murakami K, Makino H. Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 12: 317-325, 2001.
33. Sheu S, Lemasters J. Special issue: mitochondria in diseases and therapeutics. Biochim Biophys Acta 1762: 139, 2006.
34. Stone CE, Murphy MP, Smith RAJ, Oorschot DE. Are the free radical scavengers mitoquinol or N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN) protective for striatal medium-spiny neurons following an acute hypoxicischemic insult to the immature rat brain? Pedr Res 51: 444A-445A, 2002.
35. Strutz F, Okada H, Lo C, Danoff T, Carone R, Tomaszewski J, Neilson E. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130: 393-405, 1995.
36. Sunami R, Sugiyama H, Wang D, Kobayashi M, Maeshima Y, Yamasaki Y, Masuoka N, Ogawa N, Kira S, Makino H. Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Am J Physiol Renal Physiol 286: F1030-F1038, 2004.
37. Szeto HH. Cell-permeable mitochondria-targeted, peptide antioxidants. AAPS J 8: E521-E530, 2006.
38. Thomas D, Zhao K, Stauffer C, Yang H, Sharma VJ, Szeto HH, Suthanthiran M. Mitochondrial targeting of islets with the cell permeant anti-oxidant peptide SS-31 reduces islet cell apoptosis and improves post-transplant function. J Am Soc Nephrol 18: 213-222, 2007.
39. Truong LD, Choi YJ, Tsao CC, Ayala G, Sheikh-Hamad D, Nassar G, Suki WN. Renal cell apoptosis in chronic obstructive uropathy: the roles of caspases. Kidney Int 60: 924-934, 2001.
40. Wu D, Soong Y, Zhao G, Szeto HH. A highly potent peptide analgesic that protects against ischemia-reperfusion-induced myocardial stunning. Am J Physiol Heart Circ Physiol 283: H783-H791, 2002.
41. Zhang G, Oldroyd SD, Huang LH, Yang B, Li Y, Ye R, El Nahas AM. Role of apoptosis and Bcl-2/Bax in the development of tubulointerstitial fibrosis during experimental obstructive nephropathy. Exp Nephrol 9: 71-80, 2001.
42. Zhao K, Luo G, Giannelli S, Szeto HH. Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. Biochem Pharmacol 70: 1796-1806, 2005.
43. Zhao K, Luo G, Zhao GM, Schiller PW, Szeto HH. Transcellular transport of a highly polar 3- net charge opioid tetrapeptide. J Pharmacol Exp Ther 304: 425-432, 2003.
44. Zhao K, Zhao G, Wu D, Soong Y, Birk A, Schiller P, Szeto HH. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 279: 34682-34690, 2004.